Safety and efficacy of abatacept in eight rheumatoid arthritis patients with chronic hepatitis B
Arthritis Care & Research , 04/26/2012
Kim PS et al. – Use of abatacept in patients with rheumatoid arthritis (RA) and chronic hepatitis B appears feasible if antiviral prophylaxis for hepatitis B is given concurrently. In these patients there were no non–hepatitis–related adverse effects. These data are encouraging and should lead to initiation of controlled trials of abatacept in hepatitis B.